Alexandros A Drosos (A A Drosos, Drosos A Alexandros)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 46

Top Topics

Rheumatoid Arthritis

Top Venues

Rheumatology international

Clinical rheumatology

Rheumatology and therapy

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Christina Tsalapaki, Argyro Lazarini, Evangelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios T Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis. Rheumatology international 44 (4) (2024)
Venetsanopoulou I Aliki, Natasa Kalpourtzi, Yannis Alamanos, Magda Gavana, Apostolos Vantarakis, Christos S Hadjichristodoulou, Varvara A Mouchtouri, Grigoris Chlouverakis, Grigorios Trypsanis, Alexandros A Drosos, Giota Touloumi, Paraskevi Vasileios Voulgari, null null
Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO. Rheumatology international (2023)
Venetsanopoulou I Aliki, Yannis Alamanos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Decline in the incidence of rheumatoid arthritis in north-western Greece in 1980-2019. Rheumatology international (2023)
Venetsanopoulou I Aliki, Paraskevi Vasileios Voulgari, Alexandros A Drosos
TNFα inhibitor biosimilar associated with polychondritis. A case-based review. Rheumatology international (2023)
G V Papamichail, Athanasios Georgiadis, Constantinos Tellis, I Rapti, Theodora E Markatseli, V G Xydis, Alexandros D Tselepis, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study. Clinical rheumatology (2023)
Alexandros A Drosos, Alexandros A Drosos, Vassiliki Drossou, Paraskevi Vasileios Voulgari
Colchicine Against SARS-CoV-2 Infection: What is the Evidence? Rheumatology and therapy 9 (2) (2022)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
TNFα inhibitor biosimilars associated with alopecia areata. Case-based review. Rheumatology international 42 (6) (2022)
Venetsanopoulou I Aliki, Yannis Alamanos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert review of clinical immunology 18 (9) (2022)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity? Clinical rheumatology 41 (3) (2022)
Venetsanopoulou I Aliki, Yannis Alamanos, Anastasia Skalkou, Paraskevi Vasileios Voulgari, Alexandros A Drosos
The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre. Scandinavian journal of rheumatology (2022)
Alexandros A Drosos, Alexandros A Drosos
State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis. Expert opinion on pharmacotherapy 23 (6) (2022)
Paraskevi Vasileios Voulgari, Venetsanopoulou I Aliki, Pieta Antigone, Tziortzioti Zoi, Zikou K Anastasia, Alexandros A Drosos
Orbital myositis in systemic lupus erythematosus: a case-based review. Rheumatology international 42 (8) (2022)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis. Rheumatology and therapy 9 (2) (2022)
Venetsanopoulou I Aliki, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis. Expert review of clinical immunology 18 (5) (2022)
Alexandros A Drosos, Alexandros A Drosos, Vassiliki Drossou, Paraskevi Vasileios Voulgari
A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?" Rheumatology and therapy 9 (4) (2022)
Athanasios N Georgiadis, Eleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos
Correspondence on 'Cardiovascular effects of biological versus csDMARD therapy in treatment naive, early rheumatoid arthritis'. Annals of the rheumatic diseases (2021)
Alexandros A Drosos, Vassiliki Drossou, Paraskevi Vasileios Voulgari, Alexandros A Drosos
COVID-19 in patients with gout on colchicine. Rheumatology international 41 (8) (2021)
Alexandros A Drosos, Athanasios Georgiadis, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Methotrexate and interstitial lung disease. Is there a real causative factor? Rheumatology international 41 (11) (2021)
Venetsanopoulou I Aliki, Theodora E Markatseli, Chrisoula Iliou, Zoi Tziortzioti, Maria I Argyropoulou, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Pleural effusion in psoriatic arthritis patients: a case series and review of the literature. Clinical rheumatology 40 (11) (2021)
Venetsanopoulou I Aliki, Euripidis Kaltsonoudis, Alexandros A Drosos, Vassiliki Drossou, Panagiota G Karagianni, Athanasios Kavvadias, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience. Rheumatology international 41 (5) (2021)
Antigone Pieta, A Zioga, Anastasia Skalkou, Venetsanopoulou I Aliki, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Fibroblastic rheumatism: an uncommon arthritis. A case-based review. Rheumatology international (2021)
Konstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, Paraskevi V Voulgari, Alexandros A Drosos, Argyro Repa, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Panagiota Tsatsani, Sousana Gazi, Argyriou Evangelia, Kyriaki A Boki, Pelagia Katsimbri, Dimitrios Boumpas, Kalliopi Fragkiadaki, Maria G G Tektonidou, Petros P Sfikakis, Konstantina Karagianni, Lazaros I Sakkas, Eleftheria P Grika, Panagiotis G Vlachoyiannopoulos, Gerasimos Evangelatos, Alexios Iliopoulos, Theodoros Dimitroulas, Alexandros Garyfallos, Konstantinos Melissaropoulos, Panagiotis Georgiou, Maria Areti, Constantinos Georganas, Periklis Vounotrypidis, Georgios Georgiopoulos, George D Kitas, Dimitrios Vassilopoulos
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis. Rheumatology (Oxford, England) 60 (5) (2021)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Insulin resistance in patients with rheumatoid arthritis. Rheumatology international 41 (6) (2021)
Alexandros A Drosos, Paraskevi V Voulgari, Alexandros A Drosos
Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert opinion on drug discovery 16 (3) (2020)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Treatment strategies are more important than drugs in the management of rheumatoid arthritis. Clinical rheumatology 39 (4) (2020)
Antigone Pieta, Eleftherios Pelechas, Nafsika Gerolymatou, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Calcified constrictive pericarditis resulting in tamponade in a patient with systemic lupus erythematosus. Rheumatology international 41 (3) (2020)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Radiological Findings of the Cervical Spine in Rheumatoid Arthritis: What a Rheumatologist Should Know. Current rheumatology reports 22 (6) (2020)
Alexandros A Drosos, Alexandros A Drosos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari
Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment. Current rheumatology reports 22 (8) (2020)
Alexandros A Drosos, Paraskevi V Voulgari, Alexandros A Drosos
Recent advances in the opioid mu receptor based pharmacotherapy for rheumatoid arthritis. Expert opinion on pharmacotherapy 21 (17) (2020)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Occupational mimics of rheumatoid arthritis: hair dye-induced arthritis. Rheumatology international 41 (4) (2020)
Venetsanopoulou I Aliki, Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatology international 40 (8) (2020)
Alexandros A Drosos, Tereza Memi, Theodora E Markatseli, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Adalimumab-induced myasthenia gravis: case-based review. Rheumatology international 40 (11) (2020)
Evripidis Kaltsonoudis, Eleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos
Neuroinflammatory events after anti-TNFα therapy. Annals of the rheumatic diseases (2020)
Evripidis Kaltsonoudis, Eleftherios Pelechas, Alexandra Papoudou-Bai, Theodora E Markatseli, Moses Elisaf, Paraskevi V Voulgari, Alexandros A Drosos
The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital. PloS one 14 (3) (2019)
Christos G Papadopoulos, Ilias K Gartzonikas, Tatiani K Pappa, Theodora E Markatseli, Michael P Migkos, Paraskevi V Voulgari, Alexandros A Drosos
Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry. Rheumatology advances in practice 3 (1) (2019)
Alexandros A Drosos, Alexandros A Drosos
Etanercept biosimilar SB-4. Expert opinion on biological therapy 19 (3) (2019)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings. Rheumatology international 39 (8) (2019)
Alexandros A Drosos, Euripidis Kaltsonoudis, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Unmet needs in the treatment of ankylosing spondylitis: a long-term observational study from a single university center. Rheumatology international 39 (4) (2019)
Alexandros A Drosos, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs? Journal of clinical medicine 8 (8) (2019)
Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
ABP 501 for the treatment of rheumatoid arthritis. Expert opinion on biological therapy 18 (3) (2018)
Alexandros A Drosos, Alexandra Papoudou-Bai, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review. Rheumatology international 39 (2) (2018)